TScan Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-3.0M | $-7.3M | $4.2M | $515.0K |
| FY2021 | $-48.7M | $-58.6M | $9.9M | $2.5M |
| FY2022 | $-66.5M | $-70.7M | $4.2M | $4.6M |
| FY2023 | $-61.4M | $-64.5M | $3.1M | $5.2M |
| FY2024 | $-110.8M | $-114.6M | $3.8M | $9.5M |